Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

2.21
Delayed Data
As of Nov 25
 -0.02 / -0.90%
Today’s Change
1.01
Today|||52-Week Range
4.28
-41.07%
Year-to-Date
No recent news for Adaptimmune Therapeutics PLC.

Today’s Trading

Previous close2.23
Today’s open2.23
Day’s range2.19 - 2.37
Volume2,567
Average volume (3 months)428,984
Market cap$385.8M
Data as of 12:59pm ET, 11/25/2022

Growth & Valuation

Earnings growth (last year)-10.25%
Earnings growth (this year)-542.35%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+54.14%
P/E ratioNM
Price/Sales95.03
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
WVEWAVE Life Sciences L...+0.02+0.48%
PTGXProtagonist Therapeu...-0.02-0.26%
HRTXHeron Therapeutics I...+0.01+0.35%
----
Data as of 1:00pm ET, 11/25/2022

Financials

Last reporting dateNovember 25, 2022
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$6.1M
Annual profit (last year)-$158.1M
Net profit margin-2,570.99%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts